Journal of cataract and refractive surgery · 2025
Comparative evaluation of clinical results and patient-reported outcomes of enhanced monofocal and conventional monofocal intraocular lenses.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kabura Ryota, Takeshita Tetsuji, Furushima Kyoka, Iwasaki Rumi, Fukuda Rikako, Amikawa Hinako, Oshika Tetsuro
Аннотация
PURPOSE: To evaluate and compare visual performance of 2 enhanced monofocal intraocular lenses (IOLs), XY1-EM (Vivinex Impress) and DIB00V (TECNIS Eyhance), with that of a conventional monofocal IOL, XY-1 (Vivinex).
SETTING: Kamiamakusa General Hospital, Kumamoto, Japan.
METHODS: A retrospective analysis was conducted on 130 eyes from 75 patients, including 46 eyes (27 patients) implanted with XY1-EM, 47 eyes (26 patients) with DIB00V, and 37 eyes (22 patients) with XY-1.
RESULTS: Corrected distance visual acuity (CDVA) was comparable across all 3 groups. Both enhanced monofocal IOLs (XY1-EM and DIB00V) demonstrated significantly superior distance-corrected intermediate visual acuity (DCIVA) at 70 cm and 50 cm compared with the conventional monofocal IOL (XY1). The rates of spectacle independence were also significantly higher in the enhanced monofocal IOL groups. In a direct comparison between the 2 enhanced monofocal IOLs, XY1-EM exhibited a significantly better defocus curve at -1.5 diopters than DIB00V. Patients reported higher subjective satisfaction for "reading a newspaper" and "speed of adaptation to daily vision" in the XY-1 group compared with the DIB00V group.
CONCLUSIONS: The new enhanced monofocal IOL, Vivinex Impress XY1-EM, demonstrated significantly improved intermediate visual acuity compared with the conventional monofocal IOL. It also showed slightly superior intermediate visual acuity and higher subjective satisfaction compared with the other enhanced monofocal IOL evaluated in this study.
SETTING: Kamiamakusa General Hospital, Kumamoto, Japan.
METHODS: A retrospective analysis was conducted on 130 eyes from 75 patients, including 46 eyes (27 patients) implanted with XY1-EM, 47 eyes (26 patients) with DIB00V, and 37 eyes (22 patients) with XY-1.
RESULTS: Corrected distance visual acuity (CDVA) was comparable across all 3 groups. Both enhanced monofocal IOLs (XY1-EM and DIB00V) demonstrated significantly superior distance-corrected intermediate visual acuity (DCIVA) at 70 cm and 50 cm compared with the conventional monofocal IOL (XY1). The rates of spectacle independence were also significantly higher in the enhanced monofocal IOL groups. In a direct comparison between the 2 enhanced monofocal IOLs, XY1-EM exhibited a significantly better defocus curve at -1.5 diopters than DIB00V. Patients reported higher subjective satisfaction for "reading a newspaper" and "speed of adaptation to daily vision" in the XY-1 group compared with the DIB00V group.
CONCLUSIONS: The new enhanced monofocal IOL, Vivinex Impress XY1-EM, demonstrated significantly improved intermediate visual acuity compared with the conventional monofocal IOL. It also showed slightly superior intermediate visual acuity and higher subjective satisfaction compared with the other enhanced monofocal IOL evaluated in this study.